Incoming Inspection Standards: 7 Critical Checks to Prevent Costly Disputes
Incoming inspection standards should not be defined when the raw material arrives. By that point, it may already be too late.
Many disputes between buyers and suppliers do not actually start with a shipment. They start several weeks earlier, when a purchase order is issued without a sufficiently clear agreement on what “qualified” means.
A raw material arrives. The buyer’s quality team tests it according to an internal specification and finds that one parameter does not meet the requirement. The supplier then provides its Certificate of Analysis (COA) and says the same batch passed its own specification.
The buyer says the material is out of specification. The supplier says the material is compliant.
Both sides may have valid data. The problem is that they were using different definitions of acceptance.
For dietary supplement ingredients, botanical extracts, amino acids, vitamins, minerals, excipients and other functional ingredients, this can create unnecessary delays. Material may remain on hold while procurement, quality and the supplier try to determine which specification, test method or acceptance limit should apply.
The better approach is simple: define the acceptance criteria before ordering.
Why Incoming Inspection Standards Should Be Defined Before Ordering
A purchase specification is more than a list of numbers.
It should establish the quality characteristics that matter, how those characteristics will be evaluated, and what range will be considered acceptable.
For example, suppose a buyer requires a powder with a specific particle-size distribution. If the supplier’s specification only states “fine powder” while the buyer expects a defined mesh range, both parties may believe they are discussing the same product when they are not.
The same problem can occur with moisture, water activity, assay, bulk density, microbiological limits, heavy metals, solubility, appearance, viscosity or other application-specific parameters.
FDA’s dietary supplement CGMP guidance, for example, requires specifications for components and requires appropriate testing or examination to determine whether specifications are met. It also recognizes the use of supplier COAs under defined supplier-qualification and verification conditions.
The principle is relevant beyond one regulatory market: quality requirements should be established before the material is released for use, not negotiated after a shipment arrives.
1. Define the Critical Specification Parameters
The first step in establishing incoming inspection standards is deciding which parameters actually matter.
Not every characteristic needs to receive the same level of attention. Buyers should distinguish between critical quality attributes and general descriptive information.
Depending on the ingredient, critical parameters may include:
- Identity
- Assay or active content
- Purity
- Moisture
- Water activity
- Particle size
- Bulk density
- Microbiological limits
- Heavy metals
- Residual solvents
- Solubility or dispersibility
- Appearance, color or odor
- Botanical marker compounds
- Carrier or excipient composition
The important point is that the specification should reflect the intended application.
A probiotic formulation may have a very different concern about water activity than a conventional powder beverage. A capsule manufacturer may care about particle size and flow properties. A botanical extract may require specific marker compounds rather than only a general extract ratio.
A generic product description is therefore not a substitute for a purchasing specification.
2. Agree on the Test Method
A numerical limit alone may not be enough.
Two laboratories can sometimes obtain different results because they use different analytical methods, sample preparation procedures, instruments or calculation approaches.
This becomes especially important when a parameter is close to the acceptance limit.
For example, if a buyer requires moisture below a specific value, the parties should know which analytical method will be used. The same applies to assay, particle-size analysis, microbiological testing and other parameters where methodology can influence the result.
This does not necessarily mean the buyer must impose its own laboratory method on every supplier.
Instead, the important question is whether both parties have agreed on the method or on an appropriate scientifically valid method before the order is placed.
FDA’s dietary supplement CGMP guidance states that tests and examinations used to determine whether specifications are met should be appropriate and scientifically valid. This reinforces an important procurement principle: the number on the specification and the method behind the number should be considered together.
3. Define Acceptance Criteria, Not Just Target Values
One of the most common purchasing mistakes is confusing a target value with an acceptance limit.
Suppose the requested assay is “95%.” What does that mean?
Does the material need to be exactly 95%? Is 94.8% acceptable? Is 96.5% acceptable? Is the requirement “minimum 95%,” or is it a target range of 95–105%?
The same issue applies to moisture, water activity, particle size and other specifications.
Before ordering, the buyer and supplier should clarify:
- Minimum or maximum limits
- Target values
- Acceptable ranges
- Whether the requirement is contractual
- Whether an agreed deviation procedure exists
- Which result determines acceptance if the buyer and supplier obtain different results
This distinction can prevent a surprisingly large number of disputes.
A target describes what the buyer would like to receive. An acceptance criterion defines what the buyer will accept.
They are not always the same thing.
4. Make the Supplier COA Part of the Quality Process
A supplier COA should not be treated as a document that appears after shipment.
It should be part of the supplier-qualification and incoming-quality process.
A useful COA can provide information such as:
- Product and batch identification
- Test parameters
- Test methods
- Specification limits
- Actual test results
- Manufacturing or testing dates, where applicable
- Applicable remarks or release information
For companies operating under dietary supplement CGMP requirements, FDA specifically addresses the use of supplier COAs and requires defined conditions when relying on them for component specifications.
This means buyers should not simply ask whether a supplier “has a COA.” They should understand what the COA actually contains and whether the supplier’s testing and documentation are appropriate for the intended quality-control process.
For procurement teams, this is also useful before the first order. Reviewing a representative COA can reveal whether the supplier’s specification is aligned with the buyer’s own requirements.
5. Separate Supplier Specifications From Your Internal Requirements
A supplier specification and a buyer’s incoming inspection specification do not have to be identical.
The supplier may routinely control ten parameters, while the buyer may need additional parameters because of the finished formulation, regulatory market or manufacturing process.
For example, a supplier may provide a standard powder with a conventional particle-size specification. A buyer using the ingredient in a specialized powder blend may need a narrower particle-size range because flowability or blend uniformity is important.
Similarly, a supplier may provide a standard moisture specification, while the buyer may have a tighter water-activity requirement because the ingredient will be used in a moisture-sensitive formulation.
This is why simply forwarding a supplier specification to the quality department is not always enough.
The purchasing specification should reflect the buyer’s actual application and quality requirements.
6. Define What Happens When Results Do Not Match
Even with a clear specification, laboratories can occasionally produce different results.
This is why the purchase agreement or quality communication should define what happens when a result is disputed.
Questions worth clarifying include:
Who performs the initial test?
Which analytical method applies?
Will a retained or representative sample be available?
Will the supplier review the result?
When is retesting appropriate?
Will an independent laboratory be used for a disputed result?
Which result will be used for final disposition?
The purpose is not to make every possible dispute complicated. It is to avoid inventing the dispute-resolution process after the problem occurs.
A clear procedure gives both sides a defined path when a result is close to the limit or when two laboratories report different values.
7. Link Every Accepted Batch to Its Documentation
Incoming inspection standards become much more useful when they can be connected to a specific batch.
A quality document should not simply say that a product “meets specification.” The buyer should be able to connect the material received to the relevant lot or batch information and supporting documentation.
For ingredient sourcing, useful records may include:
- Purchase order
- Product specification
- Supplier information
- Batch or lot number
- COA
- SDS/MSDS where applicable
- Shipping or receiving records
- Test or inspection results
- Deviation or complaint records, if applicable
FDA’s dietary supplement CGMP framework includes receiving records and documentation related to components and supplier COAs. More broadly, traceable records allow quality teams to determine what was received, from whom, under which batch identification, and against which specification it was evaluated.
This becomes especially important when the same ingredient is purchased repeatedly or when several suppliers provide similar grades.
Incoming Inspection Standards Should Start With the Purchase Specification
The most effective incoming inspection process starts before the purchase order is issued.
Before ordering a raw material, the buyer, quality team and supplier should ideally agree on four basic elements:
What is being purchased?
Define the exact material, grade, form, source requirements and any application-specific characteristics.
What parameters determine acceptance?
Identify the critical specifications and define minimums, maximums or acceptable ranges.
How will those parameters be tested?
Agree on appropriate test methods or clearly define how differences in methodology will be handled.
What documents will support the shipment?
Confirm the required COA, specification, batch information and other quality documents before the material is shipped.
This approach turns incoming inspection from a reactive activity into a planned quality-control step.
A Practical Pre-Order Checklist
Before approving a new raw material supplier, ask:
- Is the product specification clearly defined?
- Are the critical parameters identified?
- Are minimum and maximum limits clear?
- Are target values being confused with acceptance criteria?
- Is the test method specified or agreed?
- Can the supplier provide a batch-specific COA?
- Does the COA include methods, limits and actual results where required?
- Can the batch be traced through the supplier’s documentation?
- Are application-specific requirements different from the supplier’s standard specification?
- Is there an agreed process for handling disputed results?
If several of these questions cannot be answered before the purchase order is issued, the material may not yet have a sufficiently defined purchasing specification.
Define “Acceptable” Before the Material Arrives
The purpose of incoming inspection is not to create a new negotiation after delivery.
It is to verify whether the material received matches the requirements that were already agreed.
That distinction matters.
A well-defined specification gives procurement a clear purchasing reference, gives quality teams an objective basis for inspection, and gives suppliers a clear understanding of what the buyer expects.
For ingredient sourcing, Esubio provides batch-related documentation such as COA, MSDS and product specifications, depending on the ingredient and supplier. We can also discuss critical parameters and acceptance requirements before an order is placed, helping buyers align supplier specifications with their actual purchasing and application needs.
Where appropriate, supplier information, batch documentation and quality records can be provided for customer review.
The goal is not to make procurement more complicated. It is to move the important quality conversation to the point where it is easiest to solve: before the order is placed.
When “qualified” is clearly defined before shipment, incoming inspection becomes what it should be — a straightforward verification against an agreed standard, rather than a negotiation after the problem has already arrived.
References
- U.S. FDA — Small Entity Compliance Guide: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements
FDA Dietary Supplement CGMP Compliance Guide - U.S. FDA — Current Good Manufacturing Practices (CGMPs) for Food and Dietary Supplements
FDA CGMPs for Food and Dietary Supplements - U.S. FDA — Foreign Supplier Verification Programs (FSVP)
FDA Foreign Supplier Verification Programs - U.S. FDA — Letter to Manufacturers of Dietary Supplements
FDA Letter to Manufacturers of Dietary Supplements